<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)*
Molecular Devices Corporation
----------------------------------
(Name of Issuer)
Common
----------------------------------
(Title of Class of Securities)
60851C107
----------------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement / /. (A
fee is not required only if the filing person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
Page 1 of 5 Pages
<PAGE>
CUSIP No. 60851C107 13G Page 2 of 5 Pages
--------- --- ---
- -------------------------------------------------------------------------------
(1) Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above
Persons
A. Blaine Bowman
- -------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group* (b) /X/
- -------------------------------------------------------------------------------
(3) SEC Use Only
- -------------------------------------------------------------------------------
(4) Citizenship or Place of Organization
United States
- -------------------------------------------------------------------------------
Number of Shares (5) Sole Voting
Beneficially Power 82,499
Owned by --------------------------------------------------
Each Reporting (6) Shared Voting
Person With Power 382,166 (see disclaimer of
beneficial ownership in
response to Item #4)
--------------------------------------------------
(7) Sole Dispositive
Power 82,499
--------------------------------------------------
(8) Shared Dispositive
Power 382,166 (see disclaimer
of beneficial ownership
in response to Item #4)
- -------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person
464,665
- -------------------------------------------------------------------------------
(10) Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares*
- -------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9)
5.2%
- -------------------------------------------------------------------------------
(12) Type of Reporting Person*
IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
Page 2 of 5 Pages
<PAGE>
ITEM 1(A). NAME OF ISSUER
Molecular Devices
- -------------------------------------------------------------------------------
ITEM 1(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES
1311 Orleans Drive, Sunnyvale, CA
- -------------------------------------------------------------------------------
ITEM 2(A). NAME OF PERSON(S) FILING
A. Blaine Bowman
- -------------------------------------------------------------------------------
ITEM 2(B). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE
1228 Titan Way, Sunnyvale, CA 94086
- -------------------------------------------------------------------------------
ITEM 2(C). CITIZENSHIP
United States
- -------------------------------------------------------------------------------
ITEM 2(D). TITLE OF CLASS OF SECURITIES
Common
- -------------------------------------------------------------------------------
ITEM 2(E). CUSIP NUMBER
60851C107
- -------------------------------------------------------------------------------
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b), OR 13d-2(b),
CHECK WHETHER THE PERSON FILING IS A
Not applicable.
ITEM 4. OWNERSHIP
(a) Amount Beneficially Owned:
464,665
---------------------------------------------------------------------------
(b) Percent of Class:
5.2%
---------------------------------------------------------------------------
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote
82,499*
-----------------------------------------------------------------
(ii) shared power to vote or to direct the vote
382,166*
-----------------------------------------------------------------
(iii) sole power to dispose or to direct the disposition of
82,499*
-----------------------------------------------------------------
(iv) shared power to dispose or to direct the disposition of
382,166*
-----------------------------------------------------------------
* Includes 382,166 shares beneficially owned by Dionex, of which Mr.
Bowman, a director of the Company, is President, Chief Executive Officer and
a director. Mr. Bowman disclaims beneficial ownership of the Dionex shares.
Includes 25,499 shares that may be acquired within 60 days after December 31,
1996 pursuant to oustanding stock options.
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
Not applicable.
- -------------------------------------------------------------------------------
Page 3 of 5 Pages
<PAGE>
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
Not applicable.
- -------------------------------------------------------------------------------
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
Not applicable.
- -------------------------------------------------------------------------------
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
Not applicable.
- -------------------------------------------------------------------------------
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
Not applicable.
- -------------------------------------------------------------------------------
ITEM 10. CERTIFICATION
Not applicable.
- -------------------------------------------------------------------------------
Page 4 of 5 Pages
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
2/14/97
----------------------------------------
Date
/s/ A. Blaine Bowman
----------------------------------------
Signature
A. Blaine Bowman
----------------------------------------
(Name/Title)
Page 5 of 5 Pages
